Thermo Fisher Scientific
Thermo Fisher Scientific Inc., a leading name in the life sciences and laboratory equipment industry, is headquartered in the United States. Founded in 2006 through the merger of Thermo Electron and Fisher Scientific, the company has established itself as a global powerhouse, with significant operations across North America, Europe, and Asia. Specialising in analytical instruments, reagents, and consumables, Thermo Fisher provides innovative solutions that enhance scientific research and healthcare. Their core offerings include mass spectrometry, chromatography, and molecular biology products, distinguished by their precision and reliability. With a strong market position, Thermo Fisher Scientific is recognised for its commitment to advancing scientific discovery and improving patient outcomes, making it a trusted partner for researchers and healthcare professionals worldwide.
DitchCarbon Score
How does Thermo Fisher Scientific's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Thermo Fisher Scientific's score of 97 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Thermo Fisher Scientific's reported carbon emissions
In 2024, Thermo Fisher Scientific reported total carbon emissions of approximately 282,602,000 kg CO2e, comprising 26,379,000 kg CO2e from Scope 1, 748,000 kg CO2e from Scope 2, and a significant 255,474,000 kg CO2e from Scope 3 emissions. This data reflects their commitment to transparency and accountability in environmental impact. The company has set ambitious targets to reduce its carbon footprint. By 2030, Thermo Fisher aims to achieve a 50% reduction in absolute Scope 1 and 2 emissions from a 2018 baseline. Furthermore, they are committed to reaching net-zero emissions across all scopes by 2050. This commitment includes a 90% reduction in Scope 1 and 2 emissions and a 90% reduction in Scope 3 emissions by 2050, with the latter target based on a 2021 baseline. Thermo Fisher's climate strategy aligns with the Science Based Targets initiative (SBTi), which validates their targets as consistent with the reductions necessary to limit global warming to 1.5°C. The company also aims for 90% of its suppliers, by spend, to have science-based targets by 2027, reinforcing its commitment to sustainable practices throughout its supply chain. Overall, Thermo Fisher Scientific is actively working towards significant emissions reductions, demonstrating leadership in the pharmaceutical and biotechnology sectors in addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Thermo Fisher Scientific is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
